OncoCyte

OCXNASDAQ
$3.06
0.13.38%
At Close: -
$3.09
0.030.98%
After Hours: Jul 1, 9:29 AM EDT
15 minutes delayed

OncoCyte (NASDAQ:OCX) Stock, Insider Trading Activity

OncoCyte: Insider buying and selling updated today.

Institutional Shares Held
440.431K
Institutional Percentage Held
3.30%
Apr 15, 2024BROADWOOD PARTNERS LPBROADWOOD CAPITAL INCNEAL BRADSHER10% OWNER2.42M$2.92$7.06MBUY96.44%4.929223MApr 11View
Apr 15, 2024Josh RiggsCEO AND PRESIDENT3.39K$2.95$10.00KBUY2947.83%3.505KApr 11View
Apr 15, 2024Andrew ArnoDIRECTOR33.898K$2.95$100.00KBUY78.91%76.858KApr 11View
Jun 15, 2023Alfred D KingsleyDIRECTOR30K$0.21$6.45KBUY6.55%487.878KJun 14View
Apr 07, 2023PURA VIDA INVESTMENTS LLCEfrem Kamen10% OWNER663K$0.30$200.03KBUY7.53%9.47164MApr 05View
Apr 05, 2023BROADWOOD PARTNERS LPBROADWOOD CAPITAL INCNEAL BRADSHER10% OWNER26.827638M$0.30$8.09MBUY114.86%50.18448MApr 03View
Dec 28, 2022Andrew ArnoDIRECTOR250K$0.35$87.88KBUY84.16%547.049KDec 23View
Dec 28, 2022Gutfreund John PeterDIRECTOR75K$0.33$24.73KBUY75KDec 23View
Dec 27, 2022Alfred D KingsleyDIRECTOR25K$0.28$7.12KBUY5.78%457.878KDec 22View
Aug 19, 2022Andrew LastDIRECTOR20K$0.87$17.40KBUY39.86%70.17KAug 17View
Aug 19, 2022Andrew ArnoDIRECTOR15K$0.90$13.50KBUY15KAug 17View
Aug 18, 2022Ronald AndrewsPRESIDENT & CEO40K$0.96$38.40KBUY13.64%333.212KAug 16View
Aug 17, 2022Alfred D KingsleyDIRECTOR20K$0.97$9.70KBUY4.84%432.878KAug 15View
Aug 17, 2022John Peter GutfreundDIRECTOR35K$0.93$23.25KBUY25KAug 15View
Aug 17, 2022Melinda GriffithDIRECTOR20K$1.00$10.00KBUY200.00%30KAug 15 - Aug 16View
Aug 17, 2022Jennifer L CarterDIRECTOR20.5K$0.95$9.97KBUY205.00%30.5KAug 15 - Aug 16View
Aug 17, 2022Andrew ArnoDIRECTOR160K$0.96$144.12KBUY131.09%282.049KAug 15 - Aug 16View
Jun 28, 2022PURA VIDA INVESTMENTS LLCEfrem Kamen10% OWNER-99.386K$1.03-$102.63KSELL-1.16%8.479682MJun 24View
May 19, 2022Li YuVP CNTRLLR/PRNCPL ACCTNG OFFCR16.872K$1.14-$9.27KSELL-OPTIONS16.872KMay 18View
Apr 18, 2022PURA VIDA INVESTMENTS LLCEfrem Kamen10% OWNER5.931707M$1.33$7.89MBUY1.381438MApr 14View
Apr 15, 2022BROADWOOD PARTNERS LPNEAL BRADSHERBROADWOOD CAPITAL INC10% OWNER6.003752M$1.33$8.00MBUY34.60%23.356842MApr 14View
Mar 28, 2022Douglas RossCHIEF SCIENTIFIC OFFICER15K$1.40$21.00KBUY282.11%20.317KMar 25View
Mar 17, 2022Gisela PaulsenCHIEF OPERATING OFFICER16.5K$1.20$19.77KBUY16.5KMar 17View
Mar 17, 2022Ronald AndrewsCHIEF EXECUTIVE OFFICER50K$1.28$64.15KBUY20.56%293.212KMar 16View
Mar 16, 2022Cavan RedmondDIRECTOR40K$1.19$47.56KBUY56.45%110.863KMar 16View
Mar 15, 2022Mitch LevineCHIEF FINANCIAL OFFICER25K$1.17$29.15KBUY40.27%87.08KMar 15View
Mar 22, 2021Ronald AndrewsCHIEF EXECUTIVE OFFICER11K$4.79$52.70KBUY10.71%113.698KMar 19View
Feb 09, 2021BROADWOOD PARTNERS LPBROADWOOD CAPITAL INCNEAL BRADSHER10% OWNER600K$4.50$2.70MBUY3.71%16.779629MFeb 05View
Jan 22, 2021BROADWOOD PARTNERS LPBROADWOOD CAPITAL INCNEAL BRADSHER10% OWNER1.46028M$3.42$5.00MBUY9.92%16.179629MJan 20View
Dec 28, 2020Alfred D Kingsley65.608K$1.94$86.83KOPTION EXERCISE19.45%402.878KDec 23 - Dec 28View
Dec 23, 2020Alfred D Kingsley15.692K$1.94$65.30KOPTION EXERCISE4.88%337.27KDec 21 - Dec 22View
Aug 05, 2020Albert P Parker5K$1.33$6.65KPURCHASE5KAug 03View
Aug 05, 2020Tony Kalajian5K$1.31$6.53KPURCHASE50.00%15KAug 03View
Aug 04, 2020Ronald Andrews40K$1.35$53.88KPURCHASE63.80%102.698KAug 03View
Aug 04, 2020Mitchell S Levine10K$1.32$13.20KPURCHASE37.62%36.579KAug 03View
Apr 28, 2020BROADWOOD PARTNERS LPBROADWOOD CAPITAL INCNEAL BRADSHER1.05M$2.27$2.38MPURCHASE7.68%14.719349MApr 24View
Apr 01, 2020Ronald Andrews45.216K$945.63$42.76MPURCHASE258.64%62.698KMar 30 - Mar 31View
Jan 06, 2020BROADWOOD PARTNERS LPBROADWOOD CAPITAL INCNEAL BRADSHER1.391466M$2.16$3.00MPURCHASE11.33%13.669349MJan 02View
Jan 06, 2020Lineage Cell Therapeutics Inc-2.38309M$2.16-$5.14MSELL-28.29%6.041154MJan 02View
Nov 15, 2019BROADWOOD PARTNERS LPBROADWOOD CAPITAL INCNEAL BRADSHER10% OWNER1.176471M$1.70$2.00MBUY10.60%12.277883MNov 13View
Sep 18, 2019Andrew ArnoDIRECTOR50K$2.16$108.13KBUY95.33%102.447KSep 17View
Sep 16, 2019Tony T KalajianSVP-CHIEF ACCOUNTING OFFICER10K$1.98$19.80KBUY10KSep 13View
Sep 13, 2019Lineage Cell Therapeutics Inc10% OWNER-4M$1.66-$6.64MSELL-32.20%8.424244MSep 11View
Sep 13, 2019BROADWOOD PARTNERS LPBROADWOOD CAPITAL INCNEAL BRADSHER10% OWNER2M$1.66$3.32MBUY21.97%11.101412MSep 11View
Sep 12, 2019Mitchell S LevineCHIEF FINANCIAL OFFICER10K$2.01$20.06KBUY10KSep 12View
Jul 05, 2019BIOTIME INC10% OWNER-2.25M$2.00-$4.50MSELL-15.33%12.424244MJul 05View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch